US Stock MarketDetailed Quotes

CTMX CytomX

Watchlist
  • 0.665
  • +0.048+7.71%
Close Mar 7 16:00 ET
  • 0.655
  • -0.010-1.50%
Post 19:59 ET
53.26MMarket Cap1.75P/E (TTM)

About CytomX Company

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

Company Profile

SymbolCTMX
Company NameCytomX
Listing DateOct 8, 2015
Issue Price12.00
Founded2010
CEODr. Sean A. McCarthy, D.Phil.
MarketNASDAQ
Employees121
Fiscal Year Ends12-31
Address151 Oyster Point Boulevard,Suite 400
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080-1913
Phone1-605-515-3185

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sean A. McCarthy, D.Phil.
  • Chief Executive Officer and Chairman of the Board
  • 2.61M
  • Marcia Belvin
  • Senior Vice President and Chief Scientific Officer
  • 1.21M
  • Christopher W. Ogden
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Halley E. Gilbert
  • Independent Director
  • 80.62K
  • Matthew P. Young
  • Lead Independent Director
  • 105.12K
  • Dr. Elaine V. Jones, PhD
  • Independent Director
  • 75.12K
  • Dr. Alan Ashworth, F.R.S.,PhD
  • Independent Director
  • 69.12K
  • James R. Meyers
  • Independent Director
  • 77.12K
  • Dr. Mani Mohindru, PhD
  • Independent Director
  • 78.62K
  • Dr. Zhen Su, M.D.
  • DIrector
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
As China's 'two sessions' commence: How will Chinese stocks perform?
🎙️Discussion 1. With the government's emphasis on technological innovation and sustainability, which industry sectors do you believe hold t Show More